Browse By Cancer Type Result Page of OvirusTdb

The total number of records retrieved from this search are 100. Click on ID to see further detail.
IDVirus nameVirus strainVirus genome typeVirus familyVirus genome modificationVirus aloneVirus in combination with drug/radiationImmune gene insertion in viral genomeSource of cell lineOrigin of cell lineCell lineConcentration of cell lineIn-vitro toxicityAssayIn-vitro virus concentrationIn-vitro resultModel organismIn-vivo virus concentrationIn-vivo toxicityIn-vivo resultMode of deliveryPathway inducedImmunogenic effectClinical trialPMID
OV_727Vaccinia virusVV-OncoDNAPoxviridaeThe viral thymidine kinase (TK) gene is insertionally inactivatedYesNoNoLiver Cancer Institute, Zhongshan Hospital, Fudan University, Shanghai, ChinaHuman hepatocellular carcinoma cell lineMHCC97-H5000 to 7000 cells per wellNAMTT assay1 MOI70% cancer cell viability at 96 hours post-infectionNoNoNA No responseNANANANA27441866
OV_728Vaccinia virusVV-OncoDNAPoxviridaeThe viral thymidine kinase (TK) gene is insertionally inactivatedYesNoNoLiver Cancer Institute, Zhongshan Hospital, Fudan University, Shanghai, ChinaHuman hepatocellular carcinoma cell lineMHCC97-H5000 to 7000 cells per wellNAMTT assay10 MOI50% cancer cell viability at 96 hours post-infectionNoNoNA No responseNANANANA27441866
OV_729AdenovirusAdAFPp-E1ADNAAdenoviridaeThe viral mutant with E1A gene driven by AFP promoterYesNoNoInstitute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences, and Peking Union Medical College (PUMC), Tianjin, ChinaHuman hepatocellular carcinoma cell lineHepG21.0E+4 cells per wellSlight toxicity to HL-7702 cell lineMTT assay10 MOI97% cancer cell viability on day 5NoNoNA No responseNANANANA27450327
OV_730AdenovirusAdAFPp-E1ADNAAdenoviridaeThe viral mutant with E1A gene driven by AFP promoterYesNoNoInstitute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences, and Peking Union Medical College (PUMC), Tianjin, ChinaHuman hepatocellular carcinoma cell lineHuh-71.0E+4 cells per wellSlight toxicity to HL-7702 cell lineMTT assay10 MOI100% cancer cell viability on day 5NoNoNA No responseNANANANA27450327
OV_731AdenovirusAdAFPp-E1ADNAAdenoviridaeThe viral mutant with E1A gene driven by AFP promoterYesNoNoInstitute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences, and Peking Union Medical College (PUMC), Tianjin, ChinaHuman hepatocellular carcinoma cell lineHepG21.0E+4 cells per wellSlight toxicity to HL-7702 cell lineMTT assay50 MOI52% cancer cell viability on day 5NoNoNA No responseNANANANA27450327
OV_732AdenovirusAdAFPp-E1ADNAAdenoviridaeThe viral mutant with E1A gene driven by AFP promoterYesNoNoInstitute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences, and Peking Union Medical College (PUMC), Tianjin, ChinaHuman hepatocellular carcinoma cell lineHuh-71.0E+4 cells per wellSlight toxicity to HL-7702 cell lineMTT assay50 MOI50% cancer cell viability on day 5NoNoNA No responseNANANANA27450327
OV_733AdenovirusAdAFPp-E1ADNAAdenoviridaeThe viral mutant with E1A gene driven by AFP promoterYesNoNoInstitute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences, and Peking Union Medical College (PUMC), Tianjin, ChinaHuman hepatocellular carcinoma cell lineHepG21.0E+4 cells per wellSlight toxicity to HL-7702 cell lineMTT assay100 MOI33% cancer cell viability on day 5NoNoNA No responseNANANANA27450327
OV_734AdenovirusAdAFPp-E1ADNAAdenoviridaeThe viral mutant with E1A gene driven by AFP promoterYesNoNoInstitute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences, and Peking Union Medical College (PUMC), Tianjin, ChinaHuman hepatocellular carcinoma cell lineHuh-71.0E+4 cells per wellSlight toxicity to HL-7702 cell lineMTT assay100 MOI38% cancer cell viability on day 5NoNoNA No responseNANANANA27450327
OV_735AdenovirusAdTrackDNAAdenoviridaeNoneYesNoNoInstitute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences, and Peking Union Medical College (PUMC), Tianjin, ChinaHuman hepatocellular carcinoma cell lineHepG21.0E+4 cells per wellNAMTT assay10 MOI100% cancer cell viability on day 5NoNoNA No responseNANANANA27450327
OV_736AdenovirusAdTrackDNAAdenoviridaeNoneYesNoNoInstitute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences, and Peking Union Medical College (PUMC), Tianjin, ChinaHuman hepatocellular carcinoma cell lineHuh-71.0E+4 cells per wellNAMTT assay10 MOI100% cancer cell viability on day 5NoNoNA No responseNANANANA27450327
OV_737AdenovirusAdTrackDNAAdenoviridaeNoneYesNoNoInstitute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences, and Peking Union Medical College (PUMC), Tianjin, ChinaHuman hepatocellular carcinoma cell lineHepG21.0E+4 cells per wellNAMTT assay50 MOI100% cancer cell viability on day 5NoNoNA No responseNANANANA27450327
OV_738AdenovirusAdTrackDNAAdenoviridaeNoneYesNoNoInstitute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences, and Peking Union Medical College (PUMC), Tianjin, ChinaHuman hepatocellular carcinoma cell lineHuh-71.0E+4 cells per wellNAMTT assay50 MOI100% cancer cell viability on day 5NoNoNA No responseNANANANA27450327
OV_739AdenovirusAdTrackDNAAdenoviridaeNoneYesNoNoInstitute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences, and Peking Union Medical College (PUMC), Tianjin, ChinaHuman hepatocellular carcinoma cell lineHepG21.0E+4 cells per wellNAMTT assay100 MOI100% cancer cell viability on day 5NoNoNA No responseNANANANA27450327
OV_740AdenovirusAdTrackDNAAdenoviridaeNoneYesNoNoInstitute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences, and Peking Union Medical College (PUMC), Tianjin, ChinaHuman hepatocellular carcinoma cell lineHuh-71.0E+4 cells per wellNAMTT assay100 MOI100% cancer cell viability on day 5NoNoNA No responseNANANANA27450327
OV_741AdenovirusAdAFPp-E1A-122DNAAdenoviridaeThe viral insertion mutant with miR-122 target sequence into AdAFPp-E1A for negatively regulating E1A gene expressionYesNoNoInstitute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences, and Peking Union Medical College (PUMC), Tianjin, ChinaHuman hepatocellular carcinoma cell lineHepG2 with mimics1.0E+4 cells per wellSlight toxicity to HL-7702 cell lineMTT assay50 MOI80% cancer cell viability on day 3NoNoNA No responseNANANANA27450327
OV_742AdenovirusAdAFPp-E1A-122DNAAdenoviridaeThe viral insertion mutant with miR-122 target sequence into AdAFPp-E1A for negatively regulating E1A gene expressionYesNoNoInstitute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences, and Peking Union Medical College (PUMC), Tianjin, ChinaHuman hepatocellular carcinoma cell lineHepG2 with negative control1.0E+4 cells per wellSlight toxicity to HL-7702 cell lineMTT assay50 MOI50% cancer cell viability on day 3NoNoNA No responseNANANANA27450327
OV_743AdenovirusAdAFPp-E1A-122DNAAdenoviridaeThe viral insertion mutant with miR-122 target sequence into AdAFPp-E1A for negatively regulating E1A gene expressionYesNoNoInstitute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences, and Peking Union Medical College (PUMC), Tianjin, ChinaHuman hepatocellular carcinoma cell lineHepG2 with mimics1.0E+4 cells per wellSlight toxicity to HL-7702 cell lineMTT assay100 MOI65% cancer cell viability on day 3NoNoNA No responseNANANANA27450327
OV_744AdenovirusAdAFPp-E1A-122DNAAdenoviridaeThe viral insertion mutant with miR-122 target sequence into AdAFPp-E1A for negatively regulating E1A gene expressionYesNoNoInstitute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences, and Peking Union Medical College (PUMC), Tianjin, ChinaHuman hepatocellular carcinoma cell lineHepG2 with negative control1.0E+4 cells per wellSlight toxicity to HL-7702 cell lineMTT assay100 MOI45% cancer cell viability on day 3NoNoNA No responseNANANANA27450327
OV_745AdenovirusAdAFPp-E1ADNAAdenoviridaeThe viral mutant with E1A gene driven by AFP promoterYesNoNoInstitute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences, and Peking Union Medical College (PUMC), Tianjin, ChinaHuman hepatocellular carcinoma cell lineHepG2 with mimics1.0E+4 cells per wellSlight toxicity to HL-7702 cell lineMTT assay50 MOI61% cancer cell viability on day 3NoNoNA No responseNANANANA27450327
OV_746AdenovirusAdAFPp-E1ADNAAdenoviridaeThe viral mutant with E1A gene driven by AFP promoterYesNoNoInstitute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences, and Peking Union Medical College (PUMC), Tianjin, ChinaHuman hepatocellular carcinoma cell lineHepG2 with negative control1.0E+4 cells per wellSlight toxicity to HL-7702 cell lineMTT assay50 MOI61% cancer cell viability on day 3NoNoNA No responseNANANANA27450327
OV_747AdenovirusAdAFPp-E1ADNAAdenoviridaeThe viral mutant with E1A gene driven by AFP promoterYesNoNoInstitute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences, and Peking Union Medical College (PUMC), Tianjin, ChinaHuman hepatocellular carcinoma cell lineHepG2 with mimics1.0E+4 cells per wellSlight toxicity to HL-7702 cell lineMTT assay100 MOI46% cancer cell viability on day 3NoNoNA No responseNANANANA27450327
OV_748AdenovirusAdAFPp-E1ADNAAdenoviridaeThe viral mutant with E1A gene driven by AFP promoterYesNoNoInstitute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences, and Peking Union Medical College (PUMC), Tianjin, ChinaHuman hepatocellular carcinoma cell lineHepG2 with negative control1.0E+4 cells per wellSlight toxicity to HL-7702 cell lineMTT assay100 MOI46% cancer cell viability on day 3NoNoNA No responseNANANANA27450327
OV_856AdenovirusCV890DNAAdenoviridaeE1A and E1B gene under control of Adenovirus promoterNoVirus strain in combination with Doxorubicin (10ng/ml)NoATCCHuman hepatoma cell lineHep3BNANAMTT assay0.01pfu/cell90% cancer cell killing after day 9, showing synergism with drugNoNoNA No responseNANANANA11522637
OV_857AdenovirusCV890DNAAdenoviridaeE1A and E1B gene under control of Adenovirus promoterYesNoNoATCCHuman hepatoma cell lineHep3BNANAMTT assay0.01pfu/cell35% cancer cell killing after day 9NoNoNA No responseNANANANA11522637
OV_1315AdenovirusAdCN101DNAAdenoviridae24bp deletion between E1Ap and E1AYesNoNoATCCHuman hepatocellular carcinoma cell lineHep3BNANACrystal violet staining0.01 MOIsome cells are viableNoNoNA No responseNANANANA18281783
OV_1316AdenovirusAdCN101DNAAdenoviridae24bp deletion between E1Ap and E1AYesNoNoATCCHuman hepatocellular carcinoma cell lineHep3BNANACrystal violet staining0.1 MOI100% cancer cell killingNoNoNA No responseNANANANA18281783
OV_1317AdenovirusAdCN101DNAAdenoviridae24bp deletion between E1Ap and E1AYesNoNoATCCHuman hepatocellular carcinoma cell lineHep3BNANACrystal violet staining1 MOI100% cancer cell killingNoNoNA No responseNANANANA18281783
OV_1318AdenovirusAdCN101DNAAdenoviridae24bp deletion between E1Ap and E1AYesNoNoATCCHuman hepatocellular carcinoma cell lineHep3BNANACrystal violet staining10 MOI100% cancer cell killingNoNoNA No responseNANANANA18281783
OV_1319AdenovirusAdCN101DNAAdenoviridae24bp deletion between E1Ap and E1AYesNoNoATCCHuman hepatocellular carcinoma cell lineHep3BNANACrystal violet staining100 MOI100% cancer cell killingNoNoNA No responseNANANANA18281783
OV_1320AdenovirusAdCN102DNAAdenoviridaeAddition of hTERT promoter ahead of E1AYesNoNoATCCHuman hepatocellular carcinoma cell lineHep3BNANACrystal violet staining0.01 MOIsome cells are viableNoNoNA No responseNANANANA18281783
OV_1321AdenovirusAdCN102DNAAdenoviridaeAddition of hTERT promoter ahead of E1AYesNoNoATCCHuman hepatocellular carcinoma cell lineHep3BNANACrystal violet staining0.1 MOI100% cancer cell killingNoNoNA No responseNANANANA18281783
OV_1322AdenovirusAdCN102DNAAdenoviridaeAddition of hTERT promoter ahead of E1AYesNoNoATCCHuman hepatocellular carcinoma cell lineHep3BNANACrystal violet staining1 MOI100% cancer cell killingNoNoNA No responseNANANANA18281783
OV_1323AdenovirusAdCN102DNAAdenoviridaeAddition of hTERT promoter ahead of E1AYesNoNoATCCHuman hepatocellular carcinoma cell lineHep3BNANACrystal violet staining10 MOI100% cancer cell killingNoNoNA No responseNANANANA18281783
OV_1324AdenovirusAdCN102DNAAdenoviridaeAddition of hTERT promoter ahead of E1AYesNoNoATCCHuman hepatocellular carcinoma cell lineHep3BNANACrystal violet staining100 MOI100% cancer cell killingNoNoNA No responseNANANANA18281783
OV_1325AdenovirusAdCN103DNAAdenoviridae24 bp deletion in hTERT promoterYesNoNoATCCHuman hepatocellular carcinoma cell lineHep3BNANACrystal violet staining0.01 MOIsome cells are viableNoNoNA No responseNANANANA18281783
OV_1326AdenovirusAdCN103DNAAdenoviridae24 bp deletion in hTERT promoterYesNoNoATCCHuman hepatocellular carcinoma cell lineHep3BNANACrystal violet staining0.1 MOI100% cancer cell killingNoNoNA No responseNANANANA18281783
OV_1327AdenovirusAdCN103DNAAdenoviridae24 bp deletion in hTERT promoterYesNoNoATCCHuman hepatocellular carcinoma cell lineHep3BNANACrystal violet staining1 MOI100% cancer cell killingNoNoNA No responseNANANANA18281783
OV_1328AdenovirusAdCN103DNAAdenoviridae24 bp deletion in hTERT promoterYesNoNoATCCHuman hepatocellular carcinoma cell lineHep3BNANACrystal violet staining10 MOI100% cancer cell killingNoNoNA No responseNANANANA18281783
OV_1329AdenovirusAdCN103DNAAdenoviridae24 bp deletion in hTERT promoterYesNoNoATCCHuman hepatocellular carcinoma cell lineHep3BNANACrystal violet staining100 MOI100% cancer cell killingNoNoNA No responseNANANANA18281783
OV_1330AdenovirusAdCN101DNAAdenoviridae24bp deletion between E1Ap and E1AYesNoNoShanghai institute for biological scincesHuman hepatocellular carcinoma cell lineBEL-7404NANACrystal violet staining0.01 MOISome cell are viableNoNoNA No responseNANANANA18281783
OV_1331AdenovirusAdCN101DNAAdenoviridae24bp deletion between E1Ap and E1AYesNoNoShanghai institute for biological scincesHuman hepatocellular carcinoma cell lineBEL-7404NANACrystal violet staining0.1 MOISome cell are viableNoNoNA No responseNANANANA18281783
OV_1332AdenovirusAdCN101DNAAdenoviridae24bp deletion between E1Ap and E1AYesNoNoShanghai institute for biological scincesHuman hepatocellular carcinoma cell lineBEL-7404NANACrystal violet staining1 MOI100% cell killingNoNoNA No responseNANANANA18281783
OV_1333AdenovirusAdCN101DNAAdenoviridae24bp deletion between E1Ap and E1AYesNoNoShanghai institute for biological scincesHuman hepatocellular carcinoma cell lineBEL-7404NANACrystal violet staining10 MOI100% cell killingNoNoNA No responseNANANANA18281783
OV_1334AdenovirusAdCN101DNAAdenoviridae24bp deletion between E1Ap and E1AYesNoNoShanghai institute for biological scincesHuman hepatocellular carcinoma cell lineBEL-7404NANACrystal violet staining100 MOI100% cell killingNoNoNA No responseNANANANA18281783
OV_1335AdenovirusAdCN102DNAAdenoviridaeAddition of hTERT promoter ahead of E1AYesNoNoShanghai institute for biological scincesHuman hepatocellular carcinoma cell lineBEL-7404NANACrystal violet staining0.01 MOISome cell are viableNoNoNA No responseNANANANA18281783
OV_1336AdenovirusAdCN102DNAAdenoviridaeAddition of hTERT promoter ahead of E1AYesNoNoShanghai institute for biological scincesHuman hepatocellular carcinoma cell lineBEL-7404NANACrystal violet staining0.1 MOISome cell are viableNoNoNA No responseNANANANA18281783
OV_1337AdenovirusAdCN102DNAAdenoviridaeAddition of hTERT promoter ahead of E1AYesNoNoShanghai institute for biological scincesHuman hepatocellular carcinoma cell lineBEL-7404NANACrystal violet staining1 MOI100% cell killingNoNoNA No responseNANANANA18281783
OV_1338AdenovirusAdCN102DNAAdenoviridaeAddition of hTERT promoter ahead of E1AYesNoNoShanghai institute for biological scincesHuman hepatocellular carcinoma cell lineBEL-7404NANACrystal violet staining10 MOI100% cell killingNoNoNA No responseNANANANA18281783
OV_1339AdenovirusAdCN102DNAAdenoviridaeAddition of hTERT promoter ahead of E1AYesNoNoShanghai institute for biological scincesHuman hepatocellular carcinoma cell lineBEL-7404NANACrystal violet staining100 MOI100% cell killingNoNoNA No responseNANANANA18281783
OV_1340AdenovirusAdCN103DNAAdenoviridae24 bp deletion in hTERT promoterYesNoNoShanghai institute for biological scincesHuman hepatocellular carcinoma cell lineBEL-7404NANACrystal violet staining0.01 MOISome cell are viableNoNoNA No responseNANANANA18281783
OV_1341AdenovirusAdCN103DNAAdenoviridae24 bp deletion in hTERT promoterYesNoNoShanghai institute for biological scincesHuman hepatocellular carcinoma cell lineBEL-7404NANACrystal violet staining0.1 MOISome cell are viableNoNoNA No responseNANANANA18281783
OV_1342AdenovirusAdCN103DNAAdenoviridae24 bp deletion in hTERT promoterYesNoNoShanghai institute for biological scincesHuman hepatocellular carcinoma cell lineBEL-7404NANACrystal violet staining1 MOI100% cell killingNoNoNA No responseNANANANA18281783
OV_1343AdenovirusAdCN103DNAAdenoviridae24 bp deletion in hTERT promoterYesNoNoShanghai institute for biological scincesHuman hepatocellular carcinoma cell lineBEL-7404NANACrystal violet staining10 MOI100% cell killingNoNoNA No responseNANANANA18281783
OV_1344AdenovirusAdCN103DNAAdenoviridae24 bp deletion in hTERT promoterYesNoNoShanghai institute for biological scincesHuman hepatocellular carcinoma cell lineBEL-7404NANACrystal violet staining100 MOI100% cell killingNoNoNA No responseNANANANA18281783
OV_1345AdenovirusAdCN101DNAAdenoviridae24bp deletion between E1Ap and E1AYesNoNoShanghai institute for biological scincesHuman hepatocellular carcinoma cell lineBEL-7404NANACrystal violet staining100MOI50% cell killing after 96 hoursNoNoNA No responseNANANANA18281783
OV_1346AdenovirusAdCN102DNAAdenoviridaeAddition of hTERT promoter ahead of E1AYesNoNoShanghai institute for biological scincesHuman hepatocellular carcinoma cell lineBEL-7404NANACrystal violet staining100MOI50% cell killing after 96 hoursNoNoNA No responseNANANANA18281783
OV_1347AdenovirusAdCN103DNAAdenoviridae24 bp deletion in hTERT promoterYesNoNoShanghai institute for biological scincesHuman hepatocellular carcinoma cell lineBEL-7404NANACrystal violet staining100MOI30% cell killing after 96 hoursNoNoNA No responseNANANANA18281783
OV_1348AdenovirusAdCN101DNAAdenoviridae24bp deletion between E1Ap and E1AYesNoNoShanghai institute for biological scincesHuman hepatocellular carcinoma cell lineSMMC7721NANACrystal violet staining100MOI30% cell killing after 96 hoursNoNoNA No responseNANANANA18281783
OV_1349AdenovirusAdCN102DNAAdenoviridaeAddition of hTERT promoter ahead of E1AYesNoNoShanghai institute for biological scincesHuman hepatocellular carcinoma cell lineSMMC7721NANACrystal violet staining100MOI30% cell killing after 96 hoursNoNoNA No responseNANANANA18281783
OV_1350AdenovirusAdCN103DNAAdenoviridae24 bp deletion in hTERT promoterYesNoNoShanghai institute for biological scincesHuman hepatocellular carcinoma cell lineSMMC7721NANACrystal violet staining100MOI30% cell killing after 96 hoursNoNoNA No responseNANANANA18281783
OV_2047Vaccinia virusGLV-1h68DNAPoxviridaeNoneYesNoNoATCCHuman hepatocellular carcinoma cell lineHuh-7NANAMTT assay0.1 MOI50% cell survival after 24 hoursNoNoNA No responseNAInduction of apoptosis in cancer cell lineIncreased expression of immunological gene such as GM-CSF, IFN-gamma, IL-6,2,12,18, IP-10, MCP-1,3,5, TNF-alpha and MIP-2NA21779374
OV_2048Vaccinia virusGLV-1h68DNAPoxviridaeNoneYesNoNoATCCHuman hepatocellular carcinoma cell lineHuh-7NANAMTT assay0.1 MOI20% cell survival after 48 hoursNoNoNA No responseNAInduction of apoptosis in cancer cell lineIncreased expression of immunological gene such as GM-CSF, IFN-gamma, IL-6,2,12,18, IP-10, MCP-1,3,5, TNF-alpha and MIP-2NA21779374
OV_2049Vaccinia virusGLV-1h68DNAPoxviridaeNoneYesNoNoATCCHuman hepatocellular carcinoma cell lineHuh-7NANAMTT assay0.1 MOI20% cell survival after 72 hoursNoNoNA No responseNAInduction of apoptosis in cancer cell lineIncreased expression of immunological gene such as GM-CSF, IFN-gamma, IL-6,2,12,18, IP-10, MCP-1,3,5, TNF-alpha and MIP-2NA21779374
OV_2050Vaccinia virusGLV-1h68DNAPoxviridaeNoneYesNoNoATCCHuman hepatocellular carcinoma cell lineHuh-7NANAMTT assay0.1 MOI22% cell survival after 96 hoursNoNoNA No responseNAInduction of apoptosis in cancer cell lineIncreased expression of immunological gene such as GM-CSF, IFN-gamma, IL-6,2,12,18, IP-10, MCP-1,3,5, TNF-alpha and MIP-2NA21779374
OV_2051Vaccinia virusGLV-1h68DNAPoxviridaeNoneYesNoNoATCCHuman hepatocellular carcinoma cell lineHuh-7NANAMTT assay1 MOI90% cell survival after 24 hoursNoNoNA No responseNAInduction of apoptosis in cancer cell lineIncreased expression of immunological gene such as GM-CSF, IFN-gamma, IL-6,2,12,18, IP-10, MCP-1,3,5, TNF-alpha and MIP-2NA21779374
OV_2052Vaccinia virusGLV-1h68DNAPoxviridaeNoneYesNoNoATCCHuman hepatocellular carcinoma cell lineHuh-7NANAMTT assay1 MOI58% cell survival after 48 hoursNoNoNA No responseNAInduction of apoptosis in cancer cell lineIncreased expression of immunological gene such as GM-CSF, IFN-gamma, IL-6,2,12,18, IP-10, MCP-1,3,5, TNF-alpha and MIP-2NA21779374
OV_2053Vaccinia virusGLV-1h68DNAPoxviridaeNoneYesNoNoATCCHuman hepatocellular carcinoma cell lineHuh-7NANAMTT assay1 MOI30% cell survial after 72 hoursNoNoNA No responseNAInduction of apoptosis in cancer cell lineIncreased expression of immunological gene such as GM-CSF, IFN-gamma, IL-6,2,12,18, IP-10, MCP-1,3,5, TNF-alpha and MIP-2NA21779374
OV_2054Vaccinia virusGLV-1h68DNAPoxviridaeNoneYesNoNoATCCHuman hepatocellular carcinoma cell lineHuh-7NANAMTT assay1 MOI22% cell survival after 96 hoursNoNoNA No responseNAInduction of apoptosis in cancer cell lineIncreased expression of immunological gene such as GM-CSF, IFN-gamma, IL-6,2,12,18, IP-10, MCP-1,3,5, TNF-alpha and MIP-2NA21779374
OV_2055Vaccinia virusGLV-1h68DNAPoxviridaeNoneYesNoNoATCCHuman hepatocellular carcinoma cell linePLCNANAMTT assay0.1 MOI100% cell survival after 24 hoursNoNoNA No responseNAInduction of apoptosis in cancer cell lineIncreased expression of immunological gene such as GM-CSF, IFN-gamma, IL-6,2,12,18, IP-10, MCP-1,3,5, TNF-alpha and MIP-2NA21779374
OV_2056Vaccinia virusGLV-1h68DNAPoxviridaeNoneYesNoNoATCCHuman hepatocellular carcinoma cell linePLCNANAMTT assay0.1 MOI80% cell survival after 48 hoursNoNoNA No responseNAInduction of apoptosis in cancer cell lineIncreased expression of immunological gene such as GM-CSF, IFN-gamma, IL-6,2,12,18, IP-10, MCP-1,3,5, TNF-alpha and MIP-2NA21779374
OV_2057Vaccinia virusGLV-1h68DNAPoxviridaeNoneYesNoNoATCCHuman hepatocellular carcinoma cell linePLCNANAMTT assay0.1 MOI30% cell survival after 72 hoursNoNoNA No responseNAInduction of apoptosis in cancer cell lineIncreased expression of immunological gene such as GM-CSF, IFN-gamma, IL-6,2,12,18, IP-10, MCP-1,3,5, TNF-alpha and MIP-2NA21779374
OV_2058Vaccinia virusGLV-1h68DNAPoxviridaeNoneYesNoNoATCCHuman hepatocellular carcinoma cell linePLCNANAMTT assay0.1 MOI30% cell survival after 96 hoursNoNoNA No responseNAInduction of apoptosis in cancer cell lineIncreased expression of immunological gene such as GM-CSF, IFN-gamma, IL-6,2,12,18, IP-10, MCP-1,3,5, TNF-alpha and MIP-2NA21779374
OV_2059Vaccinia virusGLV-1h68DNAPoxviridaeNoneYesNoNoATCCHuman hepatocellular carcinoma cell linePLCNANAMTT assay1 MOI80% cell survival after 24 hoursNoNoNA No responseNAInduction of apoptosis in cancer cell lineIncreased expression of immunological gene such as GM-CSF, IFN-gamma, IL-6,2,12,18, IP-10, MCP-1,3,5, TNF-alpha and MIP-2NA21779374
OV_2060Vaccinia virusGLV-1h68DNAPoxviridaeNoneYesNoNoATCCHuman hepatocellular carcinoma cell linePLCNANAMTT assay1 MOI30% cell survival after 48 hoursNoNoNA No responseNAInduction of apoptosis in cancer cell lineIncreased expression of immunological gene such as GM-CSF, IFN-gamma, IL-6,2,12,18, IP-10, MCP-1,3,5, TNF-alpha and MIP-2NA21779374
OV_2061Vaccinia virusGLV-1h68DNAPoxviridaeNoneYesNoNoATCCHuman hepatocellular carcinoma cell linePLCNANAMTT assay1 MOI20% cell survival after 72 hoursNoNoNA No responseNAInduction of apoptosis in cancer cell lineIncreased expression of immunological gene such as GM-CSF, IFN-gamma, IL-6,2,12,18, IP-10, MCP-1,3,5, TNF-alpha and MIP-2NA21779374
OV_2062Vaccinia virusGLV-1h68DNAPoxviridaeNoneYesNoNoATCCHuman hepatocellular carcinoma cell linePLCNANAMTT assay1 MOI20% cell survival after 96 hoursNoNoNA No responseNAInduction of apoptosis in cancer cell lineIncreased expression of immunological gene such as GM-CSF, IFN-gamma, IL-6,2,12,18, IP-10, MCP-1,3,5, TNF-alpha and MIP-2NA21779374
OV_2063Vaccinia virusGLV-1h68DNAPoxviridaeNoneYesNoNoATCCHuman hepatocellular carcinoma cell linePLCNANANANANAAthymic hsd nude mice xenograft for PLC cell line5.0E+6 pfuReduction in tumor volume below 2000mm compared to control after 45 days No responseNAInduction of apoptosis in cancer cell lineIncreased expression of immunological gene such as GM-CSF, IFN-gamma, IL-6,2,12,18, IP-10, MCP-1,3,5, TNF-alpha and MIP-2NA21779374
OV_2064Vaccinia virusGLV-1h68DNAPoxviridaeNoneYesNoNoATCCHuman hepatocellular carcinoma cell lineHuh-7NANANANANAAthymic hsd nude mice xenograft for PLC cell line5.0E+6 pfuReduction in tumor volume below 3000mm compared to control after 35 days NAInduction of apoptosis in cancer cell lineIncreased expression of immunological gene such as GM-CSF, IFN-gamma, IL-6,2,12,18, IP-10, MCP-1,3,5, TNF-alpha and MIP-2NA21779374
OV_2094AdenovirusMutantDNAAdenoviridaeDeletion of E1BK55KD gene and addition of AFP geneYesNoVirus expressing IL-24 geneATCCHuman hepatocellular carcinoma cell lineMRC-5NANACrystal violet staining0.1 MOINo cell killingNoNoNA No responseNAInduction of apoptosis in cancer as measured by TUNEL assayNANA21979578
OV_2095AdenovirusMutantDNAAdenoviridaeDeletion of E1BK55KD gene and addition of AFP geneYesNoVirus expressing IL-24 geneATCCHuman hepatocellular carcinoma cell lineMRC-5NANACrystal violet staining1 MOINo cell killingNoNoNA No responseNAInduction of apoptosis in cancer as measured by TUNEL assayNANA21979578
OV_2096AdenovirusMutantDNAAdenoviridaeDeletion of E1BK55KD gene and addition of AFP geneYesNoVirus expressing IL-24 geneATCCHuman hepatocellular carcinoma cell lineMRC-5NANACrystal violet staining10 MOINo cell killingNoNoNA No responseNAInduction of apoptosis in cancer as measured by TUNEL assayNANA21979578
OV_2097AdenovirusMutantDNAAdenoviridaeDeletion of E1BK55KD gene and addition of AFP geneYesNoVirus expressing IL-24 geneATCCHuman hepatocellular carcinoma cell lineMRC-5NANACrystal violet staining100 MOINo cell killingNoNoNA No responseNAInduction of apoptosis in cancer as measured by TUNEL assayNANA21979578
OV_2098AdenovirusMutantDNAAdenoviridaeDeletion of E1BK55KD gene and addition of AFP geneYesNoVirus expressing IL-24 geneATCCHuman hepatocellular carcinoma cell lineL-02NANACrystal violet staining0.1 MOINo cell killingNoNoNA No responseNAInduction of apoptosis in cancer as measured by TUNEL assayNANA21979578
OV_2099AdenovirusMutantDNAAdenoviridaeDeletion of E1BK55KD gene and addition of AFP geneYesNoVirus expressing IL-24 geneATCCHuman hepatocellular carcinoma cell lineL-02NANACrystal violet staining1 MOINo cell killingNoNoNA No responseNAInduction of apoptosis in cancer as measured by TUNEL assayNANA21979578
OV_2100AdenovirusMutantDNAAdenoviridaeDeletion of E1BK55KD gene and addition of AFP geneYesNoVirus expressing IL-24 geneATCCHuman hepatocellular carcinoma cell lineL-02NANACrystal violet staining10 MOINo cell killingNoNoNA No responseNAInduction of apoptosis in cancer as measured by TUNEL assayNANA21979578
OV_2101AdenovirusMutantDNAAdenoviridaeDeletion of E1BK55KD gene and addition of AFP geneYesNoVirus expressing IL-24 geneATCCHuman hepatocellular carcinoma cell lineL-02NANACrystal violet staining100 MOINo cell killingNoNoNA No responseNAInduction of apoptosis in cancer as measured by TUNEL assayNANA21979578
OV_2110AdenovirusMutantDNAAdenoviridaeDeletion of E1BK55KD gene and addition of AFP geneYesNoVirus expressing IL-24 geneATCCHuman hepatocellular carcinoma cell lineHuh-7NANACrystal violet staining0.1 MOISome cell death observedNoNoNA No responseNAInduction of apoptosis in cancer as measured by TUNEL assayNANA21979578
OV_2111AdenovirusMutantDNAAdenoviridaeDeletion of E1BK55KD gene and addition of AFP geneYesNoVirus expressing IL-24 geneATCCHuman hepatocellular carcinoma cell lineHuh-7NANACrystal violet staining1 MOISome cell death observedNoNoNA No responseNAInduction of apoptosis in cancer as measured by TUNEL assayNANA21979578
OV_2112AdenovirusMutantDNAAdenoviridaeDeletion of E1BK55KD gene and addition of AFP geneYesNoVirus expressing IL-24 geneATCCHuman hepatocellular carcinoma cell lineHuh-7NANACrystal violet staining10 MOISome cell death observedNoNoNA No responseNAInduction of apoptosis in cancer as measured by TUNEL assayNANA21979578
OV_2113AdenovirusMutantDNAAdenoviridaeDeletion of E1BK55KD gene and addition of AFP geneYesNoVirus expressing IL-24 geneATCCHuman hepatocellular carcinoma cell lineHuh-7NANACrystal violet staining100 MOIMost of the cells are diedNoNoNA No responseNAInduction of apoptosis in cancer as measured by TUNEL assayNANA21979578
OV_2114AdenovirusMutantDNAAdenoviridaeDeletion of E1BK55KD gene and addition of AFP geneYesNoVirus expressing IL-24 geneATCCHuman hepatocellular carcinoma cell lineHepG2NANACrystal violet staining0.1 MOISome cell death observedNoNoNA No responseNAInduction of apoptosis in cancer as measured by TUNEL assayNANA21979578
OV_2115AdenovirusMutantDNAAdenoviridaeDeletion of E1BK55KD gene and addition of AFP geneYesNoVirus expressing IL-24 geneATCCHuman hepatocellular carcinoma cell lineHepG2NANACrystal violet staining1 MOISome cell death observedNoNoNA No responseNAInduction of apoptosis in cancer as measured by TUNEL assayNANA21979578
OV_2116AdenovirusMutantDNAAdenoviridaeDeletion of E1BK55KD gene and addition of AFP geneYesNoVirus expressing IL-24 geneATCCHuman hepatocellular carcinoma cell lineHepG2NANACrystal violet staining10 MOIMost of the cells are diedNoNoNA No responseNAInduction of apoptosis in cancer as measured by TUNEL assayNANA21979578
OV_2117AdenovirusMutantDNAAdenoviridaeDeletion of E1BK55KD gene and addition of AFP geneYesNoVirus expressing IL-24 geneATCCHuman hepatocellular carcinoma cell lineHepG2NANACrystal violet staining100 MOIMost of the cells are diedNoNoNA No responseNAInduction of apoptosis in cancer as measured by TUNEL assayNANA21979578
OV_2118AdenovirusMutantDNAAdenoviridaeDeletion of E1BK55KD gene and addition of TRAIL geneYesNoVirus expressing TRAIL geneATCCHuman hepatocellular carcinoma cell lineL-02NANACrystal violet staining0.1 MOINo cell killingNoNoNA No responseNAInduction of apoptosis in cancer as measured by TUNEL assayNANA21979578
OV_2119AdenovirusMutantDNAAdenoviridaeDeletion of E1BK55KD gene and addition of TRAIL geneYesNoVirus expressing TRAIL geneATCCHuman hepatocellular carcinoma cell lineL-02NANACrystal violet staining1 MOINo cell killingNoNoNA No responseNAInduction of apoptosis in cancer as measured by TUNEL assayNANA21979578
OV_2120AdenovirusMutantDNAAdenoviridaeDeletion of E1BK55KD gene and addition of TRAIL geneYesNoVirus expressing TRAIL geneATCCHuman hepatocellular carcinoma cell lineL-02NANACrystal violet staining10 MOINo cell killingNoNoNA No responseNAInduction of apoptosis in cancer as measured by TUNEL assayNANA21979578
OV_2121AdenovirusMutantDNAAdenoviridaeDeletion of E1BK55KD gene and addition of TRAIL geneYesNoVirus expressing TRAIL geneATCCHuman hepatocellular carcinoma cell lineL-02NANACrystal violet staining100 MOINo cell killingNoNoNA No responseNAInduction of apoptosis in cancer as measured by TUNEL assayNANA21979578
OV_2130AdenovirusMutantDNAAdenoviridaeDeletion of E1BK55KD gene and addition of TRAIL geneYesNoVirus expressing TRAIL geneATCCHuman hepatocellular carcinoma cell lineHuh-7NANACrystal violet staining0.1 MOISome cell death observedNoNoNA No responseNAInduction of apoptosis in cancer as measured by TUNEL assayNANA21979578
OV_2131AdenovirusMutantDNAAdenoviridaeDeletion of E1BK55KD gene and addition of TRAIL geneYesNoVirus expressing TRAIL geneATCCHuman hepatocellular carcinoma cell lineHuh-7NANACrystal violet staining1 MOISome cell death observedNoNoNA No responseNAInduction of apoptosis in cancer as measured by TUNEL assayNANA21979578